Wednesday, December 3, 2008

Curbing Hormones' Effects In Obese Patients Could Aid Against Breast Cancer

Results from cell culture studies suggest a class of anticancer compounds called EGFR inhibitors, largely written off for breast cancers, could be effective in obese patients. The hormones leptin and IGF-1 synergistically stimulate migration and invasion in breast cancer cells. EGFR inhibitors block this stimulation.

Read More...

[Source: ScienceDaily: Latest Science News - Posted by FreeAutoBlogger]